Hospital Outcomes Among COVID-19 Hospitalizations With Myocarditis from the California State Inpatient Database

• DOI: 10.1016/j.amjcard.2022.08.009
• Publication Date: 2022-09-17T20:44:00Z
• Authors: Muni Rubens; Venkataraghavan R...; Anshul Saxena; Juan Carlos Zevallos; Juan Gabriel Ruiz...; Md Ashfaq Ahmed; Zhenwei Zhang; Peter McGranaghan; Emir Veledar; Javier Jimenez; Sandra Chaparro
• Keywords: Inpatients; Respiratory Distress Syndrome; Shock, Cardiogenic; COVID-19; Article; Hospitals; Heart Arrest; 3. Good health; Hospitalization; Myocarditis; 03 medical and health sciences; 0302 clinical medicine; Humans; Hospital Mortality; Retrospective Studies

Many case reports have indicated that myocarditis could be a prognostic factor for predicting morbidity and mortality among patients with COVID-19. In this study, using a large database we examined the association between myocarditis among COVID-19 hospitalizations and in-hospital mortality and other adverse hospital outcomes. The present study was a retrospective analysis of data collected in the California State Inpatient Database during 2020. All hospitalizations for COVID-19 were included in the analysis and grouped into those with and without myocarditis. The outcomes were in-hospital mortality, cardiac arrest, cardiogenic shock, mechanical ventilation, and acute respiratory distress syndrome. Propensity score matching, followed by conditional logistic regression, was performed to find the association between myocarditis and outcomes. Among 164,417 COVID-19 hospitalizations, 578 (0.4%) were with myocarditis. After propensity score matching, the rate of in-hospital mortality was significantly higher among COVID-19 hospitalizations with myocarditis (30.0% vs 17.5%, p <0.001). Survival analysis with log-rank test showed that 30-day survival rates were significantly lower among those with myocarditis (39.5% vs 46.3%, p <0.001). Conditional logistic regression analysis showed that the odds of cardiac arrest (odds ratio [OR] 1.90, 95% confidence interval [CI] 1.16 to 3.14), cardiogenic shock (OR 4.13, 95% CI 2.14 to 7.99), mechanical ventilation (OR 3.30, 95% CI 2.47 to 4.41), and acute respiratory distress syndrome (OR 2.49, 95% CI 1.70 to 3.66) were significantly higher among those with myocarditis. Myocarditis was associated with greater rates of in-hospital mortality and adverse hospital outcomes among patients with COVID-19, and early suspicion is important for prompt diagnosis and management.